Impax Laboratories names CEO
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Impax Laboratories Inc. appointed Paul Bisaro as the company's president and CEO, replacing J. Kevin Buchi, who had been serving in the positions on an interim basis.
Bisaro, the former executive chairman of Allergan PLC, will also join the Impax board. Bisaro continues to serve on the Allergan board.